Entera Bio (ENTX) Interest Coverage Ratio (2021 - 2026)
Entera Bio (ENTX) posted quarterly Interest Coverage Ratio of 49.15 for Q1 2026, down 7.4% year-on-year from 53.08 in Q1 2025, and down 76.88% on a QoQ basis from 27.79 in Q4 2025.
Entera Bio (ENTX) Interest Coverage Ratio (2021 - 2026) Analysis & Trends
Entera Bio (ENTX) has reported Interest Coverage Ratio for 6 consecutive years, with 49.15 the latest figure, recorded in Q1 2026.
- Quarterly Interest Coverage Ratio fell 7.4% year-over-year to 49.15 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 36.43 (down 58.01% YoY) and the FY2025 annual result came in at 0.5, down 9.34% from the prior year.
- Interest Coverage Ratio eased to 49.15 in Q1 2026 per ENTX's latest filing, from 27.79 in the prior quarter.
- Over the last five years, Interest Coverage Ratio for ENTX reached as high as 0.1 in Q4 2023 and fell as low as 94.41 in Q3 2024.
- A 5-year average of 30.46 and a median of 22.57 in 2025 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2024 — Interest Coverage Ratio sank 19883.37% — and 2025, when it surged 73.52%.
- Year by year, Interest Coverage Ratio stood at 0.17 in 2022, then jumped by 42.02% to 0.1 in 2023, then plunged by 19883.37% to 20.15 in 2024, then tumbled by 37.93% to 27.79 in 2025, then sank by 76.88% to 49.15 in 2026.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 49.15, 27.79, and 25.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -157.58 |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 7.60 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -0.38 |
| 10 | Entera Bio | 186.78 Mn | 182.64 Mn | - | -49.15 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -49.15 |
| Dec 31, 2025 | -27.79 |
| Sep 30, 2025 | -25.00 |
| Jun 30, 2025 | -84.38 |
| Mar 31, 2025 | -45.77 |
| Dec 31, 2024 | -20.15 |
| Sep 30, 2024 | -94.41 |
| Jun 30, 2024 | -9.36 |
| Dec 31, 2023 | -0.10 |
| Sep 30, 2023 | -5.00 |
| Jun 30, 2023 | -4.30 |
| Dec 31, 2022 | -0.17 |
| Dec 31, 2021 | -0.27 |